BioCentury
ARTICLE | Company News

Ex-FDA official Jenkins joins Corbus' board

June 6, 2018 2:00 PM UTC

John Jenkins, the longtime director of FDA's Office of New Drugs (OND), has been named a director at inflammatory and fibrotic disease company Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP). Jenkins joined FDA in 1992 and was OND's director from 2002-17...